The companies have extended a commercial supply partnership for the manufacture of Sohonos (palovarotene), which is a ...

As sponsors advanced more niche and personalized modalities, manufacturers were pushed to adopt holistic approaches to safety ...

FDA's Plausible Mechanism Framework streamlines individualized therapy approvals for ultra-rare diseases.

For those monitoring innovation pipelines, patent intelligence is becoming a leading indicator of competitive positioning.

Univar Solutions' Ingredients + Specialties division has been appointed as the distributor for Ingredion Pharma Solutions, ...

A: No new regulations were published in 2025 specific to data integrity. The evolving global regulatory systems do, however, ...

Innovators are increasingly focused on whether outsourced partners can help them make better decisions earlier, before ...

GSK acquires 35Pharma for $950M. The primary focus is HS235, a selective PH drug reducing bleeding risk with metabolic ...

The February 2026 meeting of the EMA's Committee for Medicinal Products for Human Use (CHMP) resulted in recommendations for twelve new medicines.¹ These outcomes, which included recommendations for ...

The rapid pace of digitalization has created a skills gap, necessitating that staff with traditional chemistry or biology degrees upskill in the IT sector . BioVectra addresses this by collaborating ...

In response to Marty Makary warning the US may lose the early‑stage drug development lead to China, Brian Scanlan says speed, ...

Continuing with the rare disease theme (Rare Disease Day is Feb 28), Elisabeth Gardiner of Tevard Biosciences explains in a video interview that research into ultra-rare conditions continues to yield ...